Clinical Trial Update: Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the safety and tolerability of combining anakinra with riluzole in patients with amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Anakinra (anakinra)
• Riluzole (riluzole)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED